Goldman Sachs Group Inc Cytek Biosciences, Inc. Transaction History

Goldman Sachs Group Inc

$706 Billion
Q2 2025

A detailed history of Goldman Sachs Group Inc transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,016,557 shares of CTKB stock, worth $4.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,016,557

Previous 1,158,001 12.21%

Holding current value

$4.09 Million

Previous $4.64 Million 25.57%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$2.42 - $3.99 $342,294 - $564,361	-141,444 Reduced 12.21%	1,016,557 $3.46 Million
Q1 2025 May 09, 2025	SELL	$4.0 - $7.26 $735,004 - $1.33 Million	-183,751 Reduced 13.69%	1,158,001 $4.64 Million
Q4 2024 Feb 11, 2025	BUY	$4.7 - $7.4 $1.5 Million - $2.36 Million	319,008 Added 31.19%	1,341,752 $8.71 Million
Q3 2024 Nov 14, 2024	SELL	$4.73 - $6.73 $1.58 Million - $2.25 Million	-334,507 Reduced 24.65%	1,022,744 $5.67 Million
Q2 2024 Aug 13, 2024	BUY	$5.3 - $6.91 $4.2 Million - $5.48 Million	793,236 Added 140.64%	1,357,251 $7.57 Million
Q1 2024 May 15, 2024	BUY	$6.29 - $9.15 $7,774 - $11,309	1,236 Added 0.22%	564,015 $3.78 Million
Q4 2023 Feb 13, 2024	BUY	$4.1 - $9.51 $100,138 - $232,272	24,424 Added 4.54%	562,779 $5.13 Million
Q3 2023 May 14, 2024	SELL	$5.52 - $9.5 $134,820 - $232,028	-24,424 Reduced 4.34%	538,355 $2.97 Million
Q3 2023 Nov 14, 2023	SELL	$5.52 - $9.5 $165,820 - $285,380	-30,040 Reduced 5.29%	538,355 $2.97 Million
Q2 2023 May 14, 2024	BUY	$6.69 - $11.99 $2.43 Million - $4.36 Million	363,261 Added 177.08%	568,395 $4.85 Million
Q2 2023 Aug 14, 2023	BUY	$6.69 - $11.99 $2.43 Million - $4.36 Million	363,261 Added 177.08%	568,395 $4.85 Million
Q1 2023 May 14, 2024	SELL	$8.44 - $13.47 $1.32 Million - $2.11 Million	-156,988 Reduced 43.35%	205,134 $1.89 Million
Q1 2023 May 11, 2023	SELL	$8.44 - $13.47 $1.32 Million - $2.11 Million	-156,988 Reduced 43.35%	205,134 $1.89 Million
Q4 2022 May 14, 2024	BUY	$9.71 - $15.86 $2.56 Million - $4.18 Million	263,644 Added 267.72%	362,122 $3.7 Million
Q4 2022 Feb 13, 2023	BUY	$9.71 - $15.86 $2.56 Million - $4.18 Million	263,644 Added 267.72%	362,122 $3.7 Million
Q3 2022 May 14, 2024	BUY	$10.96 - $15.45 $258,502 - $364,403	23,586 Added 31.49%	98,478 $1.45 Million
Q3 2022 Nov 10, 2022	BUY	$10.96 - $15.45 $258,502 - $364,403	23,586 Added 31.49%	98,478 $1.45 Million
Q2 2022 May 14, 2024	SELL	$7.41 - $11.56 $3.62 Million - $5.64 Million	-487,887 Reduced 86.69%	74,892 $803,000
Q2 2022 Aug 15, 2022	SELL	$7.41 - $11.56 $4.26 Million - $6.64 Million	-574,397 Reduced 88.47%	74,892 $803,000
Q1 2022 May 16, 2022	BUY	$9.89 - $17.25 $5.83 Million - $10.2 Million	589,229 Added 981.07%	649,289 $7 Million
Q4 2021 Feb 14, 2022	SELL	$16.14 - $25.04 $149,488 - $231,920	-9,262 Reduced 13.36%	60,060 $980,000
Q3 2021 Nov 10, 2021	BUY	$17.52 - $27.93 $1.21 Million - $1.94 Million	69,322 New	69,322 $1.48 Million

Others Institutions Holding CTKB

# of Institutions

156

Shares Held

74M

Call Options Held

Put Options Held

View Full List

About Cytek Biosciences, Inc.

Ticker CTKB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 134,627,008
Market Cap $541M
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...

More about CTKB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Cytek Biosciences, Inc. Transaction History